Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCH1 in Acute Infectious Conjunctivitis
NCT05356793Phase 2Completed
- Sponsor
- Sachs Associates
- Start
- Mar 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SCH1 in acute infectious conjunctivitis, sponsored by Sachs Associates. Started Mar 2021; status: completed.
02
Drugs
SCH1
03
Conditions
acute infectious conjunctivitis
Beyond the preview
Go deeper on NCT05356793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05356793.